Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -22,9 +22,6 @@
22	22	Jubilant Pharmova Limited has a team of around 7,700 multicultural people across the globe and is committed to delivering value to its customers in over 100 countries. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals and life sciences companies worldwide.
23	23
24	24
25		-[[image:JUBLPHARMA1.png]]
26		-
27		-
28	28	= Business Segments =
29	29
30	30	== Pharmaceuticals ==
...	...	@@ -76,6 +76,7 @@
76	76	* Synthetic & Developmental Chemistry
77	77	* Pharmacology
78	78
	76	+
79	79	Jubilant Biosys collaborates with the world’s leading pharmaceutical, biotech companies, academic institutions and research foundations.
80	80
81	81
...	...	@@ -108,9 +108,6 @@
108	108	The global crop protection chemicals market size was US$ 58.4 billion in 2019 and is anticipated to expand at a CAGR of 3.3% from 2020 to 2027. Greater emphasis on high crop output to counter food security is the key growth driver.
109	109
110	110
111		-[[image:JUBLPHARMA2.png]]
112		-
113		-
114	114	= Financial Overview =
115	115
116	116
...	...	@@ -139,9 +139,6 @@
139	139	The Drug Discovery & Development Solutions (DDDS) segment includes its Drug Discovery Services (Jubilant Biosys Limited and Jubilant Chemsys Limited) & Proprietary Drug Discovery (Jubilant Therapeutics Inc.) businesses. Revenues in FY 2020 were at Rs 2,615 million as compared to Rs 2,168 million in the previous year, up 21% YoY.
140	140
141	141
142		-[[image:JUBLPHARMA3.png]]
143		-
144		-
145	145	== FY21 results ==
146	146
147	147